Important R&D Tax changes and exemptions for Life Sciences industry
Tax rules on claiming relief for research and development (R&D) are being tightened. However, the reforms include exceptions designed to…
More
Whatever else about 2020’s pandemic and its devastating impact on lives and livelihoods, it was not unpredicted. A flu-like pandemic…
Taking the panic out of pandemic
2020 was a big year for pharmaceuticals, and 2021 has been no different. The sector was thrown into the public…
Year in review: Life sciences
We all know how important R&D tax credits are for the Life Sciences, Pharmaceuticals, and Biotech sectors. Most companies in…
Life Sciences sector may be underclaiming R&D tax credits
After the public health cataclysm of 2020, the importance of pharmaceutical R&D – and arming the body’s immune system, in…
Upping the anti
As we say farewell to 2020, Ayming reflects on the key stories, opinions and coverage that have shaped the year.…
Bioprinting, psychedelics and record-breaking innovation – The 2020 life sciences round up
The world has breathed a collective sigh of relief. After nine months of waiting, vaccines are inbound. The recent announcements…
What lessons can we learn from vaccine R&D process?
3D bioprinting – The next step in tailor-made medicine
From aerospace components to complete building structures, 3D printing technologies are at the forefront of innovation across a range of industries.…
More
The use of psychedelic drugs to treat mental illnesses is nothing new, it was first introduced over 70 years ago…
Psychedelic drugs and mental health – A breakthrough treatment?
The good news is we’re living longer. But that’s not so good if it means potentially living longer with debilitating…
Agetech – A cure for ageing?
The world is changing at a rate faster than we’ve ever seen before. A large proportion of that change can…
Making science fiction, fact